Gastric Invasive Micropapillary Carcinoma with Intestinal Phenotypes Harboring a TP53 R175H Mutation

Hideyuki Ikeda1, Takehiro Kukitsu2, Wataru Johmen3

  • 1Divisions of Surgical Pathology, Rumoi City Hospital, Rumoi, Japan.

Case Reports in Oncology
|November 20, 2014
PubMed

Insights

This case study highlights gastric invasive micropapillary carcinoma (IMPC), a rare subtype of gastric cancer. The study identifies a TP53 R175H mutation, linked to increased cancer invasiveness and metastasis.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Gastric invasive micropapillary carcinoma (IMPC) is a rare and aggressive subtype of gastric adenocarcinoma.
  • Early diagnosis and understanding of its behavior are crucial for patient outcomes.

Observation:

  • An 86-year-old female presented with bloody emesis, diagnosed with gastric adenocarcinoma.
  • Pathological examination revealed invasive micropapillary carcinoma with submucosal invasion and extensive lymph node metastases.
  • Immunohistochemical staining (D2-40 and CD10) confirmed IMPC features and lymphatic vessel invasion.

Findings:

  • The gastric IMPC exhibited intestinal phenotypes.
  • A TP53 gene mutation (R175H) was identified, a known 'gain-of-function' mutation associated with high metastatic potential.
  • CD10 staining demonstrated the characteristic inverted apical-basal pattern of IMPC.

Implications:

  • This case provides insights into the clinicopathological and molecular characteristics of gastric IMPC.
  • The TP53 R175H mutation may contribute to the aggressive behavior and metastasis observed in this patient.
  • Further research into gastric IMPC with intestinal phenotypes and specific mutations is warranted.